Stoke Therapeutics, Inc.
STOK
Revenue
158.57M
▲135.96M▲601.20%
3 Months ChangeAssets
406.89M
▲135.33M▲49.84%
3 Months ChangeLiabilities
56.81M
▲14.28M▲33.57%
3 Months ChangeFree Cash Flow
131.68M
▲156.25M▲635.74%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-10
Form 8-K
ID: 0001193125-24-216632
2024-08-07
Form 10-Q
ID: 0000950170-24-092738
2024-08-07
Form 8-K
ID: 0000950170-24-092268
2024-06-21
Form 8-K
ID: 0001193125-24-165651
2024-06-06
Form 8-K
ID: 0001193125-24-156049
2024-05-06
Form 10-Q
ID: 0000950170-24-053535
2024-05-06
Form 8-K
ID: 0000950170-24-053195
2024-04-29
Form 8-K
ID: 0001193125-24-122215
2024-03-28
Form 8-K
ID: 0001193125-24-080874
2024-03-25
Form 8-K
ID: 0001193125-24-076478